NCT00392834: Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma |
|
|
| Completed | 2 | 34 | US | filgrastim, pegfilgrastim, rituximab, cyclophosphamide, cytarabine, doxorubicin hydrochloride, etoposide, ifosfamide, leucovorin calcium, liposomal cytarabine, methotrexate, therapeutic hydrocortisone, vincristine sulfate | AIDS Malignancy Consortium, National Cancer Institute (NCI), The Emmes Company, LLC | Lymphoma | 07/11 | 07/13 | | |
NCT00133991: Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia |
|
|
| Completed | 2 | 23 | US | Filgrastim, Neupogen, G-CSF, Rituximab, Rituxan, Cyclophosphamide, Cytoxan, Cy, CTX, HiCy, Cytarabine, Ara-C, Methotrexate, MTX, Prednisone, Deltasone, Hydrocortisone, Vincristine, Oncovin, Leucovorin, Folinic acid | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, National Cancer Institute (NCI) | Leukemia, Lymphoma | 08/11 | 08/13 | | |